Global Alogliptin Market Research Report 2021
Table of Content
1 Alogliptin Market Overview
- 1.1 Product Overview and Scope of Alogliptin
- 1.2 Alogliptin Segment by Type
- 1.2.1 Global Alogliptin Sales Growth Rate Comparison by Type (2021-2027)
- 1.2.2 6.25 Mg Tablet
- 1.2.3 25 Mg Tablet
- 1.2.4 12.5 Mg Tablet
- 1.2.5 15 Mg Tablet
- 1.2.6 Other
- 1.3 Alogliptin Segment by Application
- 1.3.1 Alogliptin Sales Comparison by Application: (2021-2027)
- 1.3.2 Diabetes
- 1.3.3 Hypercholesterolemia
- 1.3.4 Obesity
- 1.3.5 Other
- 1.4 Global Alogliptin Market Size Estimates and Forecasts
- 1.4.1 Global Alogliptin Revenue 2016-2027
- 1.4.2 Global Alogliptin Sales 2016-2027
- 1.4.3 Alogliptin Market Size by Region: 2016 Versus 2021 Versus 2027
2 Alogliptin Market Competition by Manufacturers
- 2.1 Global Alogliptin Sales Market Share by Manufacturers (2016-2021)
- 2.2 Global Alogliptin Revenue Market Share by Manufacturers (2016-2021)
- 2.3 Global Alogliptin Average Price by Manufacturers (2016-2021)
- 2.4 Manufacturers Alogliptin Manufacturing Sites, Area Served, Product Type
- 2.5 Alogliptin Market Competitive Situation and Trends
- 2.5.1 Alogliptin Market Concentration Rate
- 2.5.2 The Global Top 5 and Top 10 Largest Alogliptin Players Market Share by Revenue
- 2.5.3 Global Alogliptin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Alogliptin Retrospective Market Scenario by Region
- 3.1 Global Alogliptin Retrospective Market Scenario in Revenue by Region: 2016-2021
- 3.2 Global Alogliptin Retrospective Market Scenario in Sales by Region: 2016-2021
- 3.3 North America Alogliptin Market Facts & Figures by Country
- 3.3.1 North America Alogliptin Sales by Country
- 3.3.2 North America Alogliptin Revenue by Country
- 3.3.3 U.S.
- 3.3.4 Canada
- 3.4 Europe Alogliptin Market Facts & Figures by Country
- 3.4.1 Europe Alogliptin Sales by Country
- 3.4.2 Europe Alogliptin Revenue by Country
- 3.4.3 Germany
- 3.4.4 France
- 3.4.5 U.K.
- 3.4.6 Italy
- 3.4.7 Russia
- 3.5 Asia Pacific Alogliptin Market Facts & Figures by Region
- 3.5.1 Asia Pacific Alogliptin Sales by Region
- 3.5.2 Asia Pacific Alogliptin Revenue by Region
- 3.5.3 China
- 3.5.4 Japan
- 3.5.5 South Korea
- 3.5.6 India
- 3.5.7 Australia
- 3.5.8 Taiwan
- 3.5.9 Indonesia
- 3.5.10 Thailand
- 3.5.11 Malaysia
- 3.5.12 Philippines
- 3.5.13 Vietnam
- 3.6 Latin America Alogliptin Market Facts & Figures by Country
- 3.6.1 Latin America Alogliptin Sales by Country
- 3.6.2 Latin America Alogliptin Revenue by Country
- 3.6.3 Mexico
- 3.6.4 Brazil
- 3.6.5 Argentina
- 3.7 Middle East and Africa Alogliptin Market Facts & Figures by Country
- 3.7.1 Middle East and Africa Alogliptin Sales by Country
- 3.7.2 Middle East and Africa Alogliptin Revenue by Country
- 3.7.3 Turkey
- 3.7.4 Saudi Arabia
- 3.7.5 UAE
4 Global Alogliptin Historic Market Analysis by Type
- 4.1 Global Alogliptin Sales Market Share by Type (2016-2021)
- 4.2 Global Alogliptin Revenue Market Share by Type (2016-2021)
- 4.3 Global Alogliptin Price by Type (2016-2021)
5 Global Alogliptin Historic Market Analysis by Application
- 5.1 Global Alogliptin Sales Market Share by Application (2016-2021)
- 5.2 Global Alogliptin Revenue Market Share by Application (2016-2021)
- 5.3 Global Alogliptin Price by Application (2016-2021)
6 Key Companies Profiled
- 6.1 Takeda
- 6.1.1 Takeda Corporation Information
- 6.1.2 Takeda Description and Business Overview
- 6.1.3 Takeda Alogliptin Sales, Revenue and Gross Margin (2016-2021)
- 6.1.4 Takeda Product Portfolio
- 6.1.5 Takeda Recent Developments/Updates
- 6.2 Perrigo
- 6.2.1 Perrigo Corporation Information
- 6.2.2 Perrigo Description and Business Overview
- 6.2.3 Perrigo Alogliptin Sales, Revenue and Gross Margin (2016-2021)
- 6.2.4 Perrigo Product Portfolio
- 6.2.5 Perrigo Recent Developments/Updates
- 6.3 Hikma Pharmaceuticals
- 6.3.1 Hikma Pharmaceuticals Corporation Information
- 6.3.2 Hikma Pharmaceuticals Description and Business Overview
- 6.3.3 Hikma Pharmaceuticals Alogliptin Sales, Revenue and Gross Margin (2016-2021)
- 6.3.4 Hikma Pharmaceuticals Product Portfolio
- 6.3.5 Hikma Pharmaceuticals Recent Developments/Updates
- 6.4 Furiex Pharma
- 6.4.1 Furiex Pharma Corporation Information
- 6.4.2 Furiex Pharma Description and Business Overview
- 6.4.3 Furiex Pharma Alogliptin Sales, Revenue and Gross Margin (2016-2021)
- 6.4.4 Furiex Pharma Product Portfolio
- 6.4.5 Furiex Pharma Recent Developments/Updates
- 6.5 Allergan
- 6.5.1 Allergan Corporation Information
- 6.5.2 Allergan Description and Business Overview
- 6.5.3 Allergan Alogliptin Sales, Revenue and Gross Margin (2016-2021)
- 6.5.4 Allergan Product Portfolio
- 6.5.5 Allergan Recent Developments/Updates
- 6.6 Sanofi
- 6.6.1 Sanofi Corporation Information
- 6.6.2 Sanofi Description and Business Overview
- 6.6.3 Sanofi Alogliptin Sales, Revenue and Gross Margin (2016-2021)
- 6.6.4 Sanofi Product Portfolio
- 6.6.5 Sanofi Recent Developments/Updates
7 Alogliptin Manufacturing Cost Analysis
- 7.1 Alogliptin Key Raw Materials Analysis
- 7.1.1 Key Raw Materials
- 7.1.2 Key Suppliers of Raw Materials
- 7.2 Proportion of Manufacturing Cost Structure
- 7.3 Manufacturing Process Analysis of Alogliptin
- 7.4 Alogliptin Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
- 8.1 Marketing Channel
- 8.2 Alogliptin Distributors List
- 8.3 Alogliptin Customers
9 Alogliptin Market Dynamics
- 9.1 Alogliptin Industry Trends
- 9.2 Alogliptin Growth Drivers
- 9.3 Alogliptin Market Challenges
- 9.4 Alogliptin Market Restraints
10 Global Market Forecast
- 10.1 Alogliptin Market Estimates and Projections by Type
- 10.1.1 Global Forecasted Sales of Alogliptin by Type (2022-2027)
- 10.1.2 Global Forecasted Revenue of Alogliptin by Type (2022-2027)
- 10.2 Alogliptin Market Estimates and Projections by Application
- 10.2.1 Global Forecasted Sales of Alogliptin by Application (2022-2027)
- 10.2.2 Global Forecasted Revenue of Alogliptin by Application (2022-2027)
- 10.3 Alogliptin Market Estimates and Projections by Region
- 10.3.1 Global Forecasted Sales of Alogliptin by Region (2022-2027)
- 10.3.2 Global Forecasted Revenue of Alogliptin by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
- 12.1 Methodology/Research Approach
- 12.1.1 Research Programs/Design
- 12.1.2 Market Size Estimation
- 12.1.3 Market Breakdown and Data Triangulation
- 12.2 Data Source
- 12.2.1 Secondary Sources
- 12.2.2 Primary Sources
- 12.3 Author List
Description
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
6.25 Mg Tablet
25 Mg Tablet
12.5 Mg Tablet
15 Mg Tablet
Other
Segment by Application
Diabetes
Hypercholesterolemia
Obesity
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Takeda
Perrigo
Hikma Pharmaceuticals
Furiex Pharma
Allergan
Sanofi